SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Credit Suisse Maintains Outperform on Macrogenics, Raises Price Target to $30

Credit Suisse maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target from $13 to $30.

Benzinga · 05/12/2020 12:09

Credit Suisse maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target from $13 to $30.